| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.3 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.075 | 0.3 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.05 | 0.3 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.3 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |